STATE STREET CORP - ATYR PHARMA INC ownership

ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 43 filers reported holding ATYR PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q3 2023$263,557
-26.9%
166,8080.0%0.00%
Q2 2023$360,305
+106.9%
166,808
+101.2%
0.00%
Q1 2023$174,107
-52.1%
82,908
-50.0%
0.00%
Q4 2022$363,138
+45.8%
165,816
+100.0%
0.00%
Q3 2022$249,000
+6.0%
82,9080.0%0.00%
Q2 2022$235,000
-47.1%
82,9080.0%0.00%
Q1 2022$444,000
+6.2%
82,908
+48.1%
0.00%
Q4 2021$418,000
-17.7%
55,9990.0%0.00%
Q3 2021$508,000
+88.8%
55,999
+1.4%
0.00%
Q2 2021$269,00055,1990.00%
Other shareholders
ATYR PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,626,624$7,310,0662.43%
Tikvah Management LLC 2,460,833$3,888,1161.40%
TANG CAPITAL MANAGEMENT LLC 471,134$744,3920.10%
FEDERATED HERMES, INC. 10,169,600$16,067,9680.04%
Alyeska Investment Group, L.P. 2,455,555$3,879,7770.03%
XTX Topco Ltd 73,894$116,7530.02%
ALTERNA WEALTH MANAGEMENT, INC 10,000$15,8000.02%
Pale Fire Capital SE 55,857$88,2540.01%
GSA CAPITAL PARTNERS LLP 27,559$440.00%
Virtu Financial LLC 13,662$220.00%
View complete list of ATYR PHARMA INC shareholders